Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Arleta Kulwas"'
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
The quotient of concentrations concerning the key proangiogenic factor, that is, the vascular endothelial growth factor (VEGF-A) and the angiogenesis inhibitor, namely, its soluble receptors (sVEGFR-1 or sVEGFR-2), seems to reflect increased hypoxia
Externí odkaz:
https://doaj.org/article/657ac5f91d6944f59fdae6c8a651ffa7
Publikováno v:
Medicina, Vol 55, Iss 7, p 395 (2019)
Background and objectives: Both in the pathogenesis of type 2 diabetes (DM 2) and Peripheral Arterial Disease (PAD), a vital role is played by endothelial dysfunction. Metabolic disorders found in DM 2 (hyperglycemia, insulin resistance), endothelial
Externí odkaz:
https://doaj.org/article/592e02a605d149d596044d2f3296efcd
Autor:
Maciej Bierwagen, Marcin Wierciński, Krzysztof Góralczyk, Barbara Góralczyk, Andrzej Janczarek, Arleta Kulwas, Danuta Rość, Barbara Ruszkowska-Ciastek
Publikováno v:
Blood Coagulation & Fibrinolysis. 33:438-448
The aim of the study was to investigate the concentration and activity of tissue factor (TF) and Tissue factor pathway inhibitor (TFPI) as well as the concentration of thrombin-antithrombin (TAT) complexes in patients with primary and metastatic intr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::944f9bcbebcbebc518477ae08b879c7b
https://doi.org/10.1097/mbc.0000000000001164
https://doi.org/10.1097/mbc.0000000000001164
Publikováno v:
Exp Biol Med (Maywood)
Asymmetric dimethylarginine is an endogenous competitive inhibitor of nitric oxide synthase and marker of endothelial dysfunction, but the question remains as to whether asymmetric dimethylarginine is a marker of cardiovascular episodes or their inde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cea4256de9ccd4cad4684076875f1f32
https://doi.org/10.1177/1535370220959738
https://doi.org/10.1177/1535370220959738
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 3, p 659 (2020)
Volume 9
Issue 3
Journal of Clinical Medicine, Vol 9, Iss 3, p 659 (2020)
Volume 9
Issue 3
Background: Atherosclerosis is a systemic disease. Among patients with atherosclerosis, those suffering from peripheral arterial disease (PAD) represent a group of individuals with particularly high death risk, especially during the course of critica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d44fc60e236e15118798b9e592b15160
https://pubmed.ncbi.nlm.nih.gov/32121363
https://pubmed.ncbi.nlm.nih.gov/32121363
Autor:
Beata Lisewska, Wiesław Jundziłł, Zofia Ruprecht, Wanda Drewniak, Arleta Kulwas, Grażyna Gadomska, Barbara Ruszkowska, Danuta Rość
Publikováno v:
Advances in Medical Sciences. 62:87-91
Purpose The aim was to evaluate tissue plasminogen activator (tPA) and plasminogen activator inhibitor type 1 (PAI-1) concentration using enzyme linked immunosorbent assay method (ELISA) in diabetic foot syndrome (DFS) as compared to a group of healt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1c2718d14621b91dec1420543dc2c8d
https://doi.org/10.1016/j.advms.2016.07.007
https://doi.org/10.1016/j.advms.2016.07.007
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
Clinical and Applied Thrombosis/Hemostasis
Clinical and Applied Thrombosis/Hemostasis
The quotient of concentrations concerning the key proangiogenic factor, that is, the vascular endothelial growth factor (VEGF-A) and the angiogenesis inhibitor, namely, its soluble receptors (sVEGFR-1 or sVEGFR-2), seems to reflect increased hypoxia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12e31d54df834016dd4ab7cf75f7e82b
https://doaj.org/article/657ac5f91d6944f59fdae6c8a651ffa7
https://doaj.org/article/657ac5f91d6944f59fdae6c8a651ffa7
Publikováno v:
Medicina; Volume 55; Issue 7; Pages: 395
Medicina
Volume 55
Issue 7
Medicina, Vol 55, Iss 7, p 395 (2019)
Medicina
Volume 55
Issue 7
Medicina, Vol 55, Iss 7, p 395 (2019)
Background and objectives: Both in the pathogenesis of type 2 diabetes (DM 2) and Peripheral Arterial Disease (PAD), a vital role is played by endothelial dysfunction. Metabolic disorders found in DM 2 (hyperglycemia, insulin resistance), endothelial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::408b7b34cd6449910724a03339b85884
Autor:
Jacek Budzyński, Arleta Kulwas, Danuta Rość, Anna Maria Wieczór, Radosław Wieczór, Grzegorz Pulkowski
Publikováno v:
Journal of Zhejiang University. Science. B. 20(8)
The objective of this study was to assess the angiogenic potential expressed as a quotient of vascular endothelial growth factor A (VEGF-A), as an indicator of proangiogenic activity, and the circulating receptors (soluble VEGF receptor protein R1 (s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6781403cca4ddf2c834dd695c0b3e385
https://pubmed.ncbi.nlm.nih.gov/31273966
https://pubmed.ncbi.nlm.nih.gov/31273966
Publikováno v:
International Angiology. 37
Competitive inhibition of endothelial nitric oxide synthase (eNOS) is the main biological effect of asymmetric dimethylarginine (ADMA), i.e. the methylated derivative of L-arginine. The resulting low level of NO is becoming one of the elements of pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6060356bdcfa6e5b18b27ebd9b50a0ab
https://doi.org/10.23736/s0392-9590.18.04017-8
https://doi.org/10.23736/s0392-9590.18.04017-8